UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000007870 |
|---|---|
| Receipt number | R000009254 |
| Scientific Title | Study of the relationship between pathophysiology of neurological disease including multiple sclerosis and function of LOTUS |
| Date of disclosure of the study information | 2012/05/02 |
| Last modified on | 2019/05/26 00:19:58 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Study of the relationship between pathophysiology of neurological disease including multiple sclerosis and function of LOTUS
Acronym
Study of the relationship between pathophysiology of neurological disease including multiple sclerosis and function of LOTUS
Scientific Title
Study of the relationship between pathophysiology of neurological disease including multiple sclerosis and function of LOTUS
Scientific Title:Acronym
Study of the relationship between pathophysiology of neurological disease including multiple sclerosis and function of LOTUS
Region
| Japan |
Condition
Condition
multiple sclerosis(MS) and related disease of MS, other neurological diseases
Classification by specialty
| Neurology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
The purpose of this study is to find the relationship between Pathophysiology of multiple sclerosis (MS) and its related disease by analyzing expression pattern and function of LOTUS, and to aim at developing a new biomarker and new therapy.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Detection or not, concentration and specificity of LOTUS in biological sample including cerebrospinal fluid and blood in patients with multiple sclerosis
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Patients who fit into diagnostic criteria for multiple sclerosis and we have their cerebrospinal fluid or blood sample.
Neurological diseases except for multiple sclerosis
Key exclusion criteria
none
Target sample size
200
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Fumiaki Tanaka |
Organization
Yokohama City University school of medicine
Division name
Department of Neurology and stroke medicine
Zip code
Address
3-9 Fukuura Kanazawa-ku Yokohama
TEL
045-787-2800
ftanak@yokohama-cu.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Keita Takahashi |
Organization
Yokohama City University school of medicine
Division name
Department of Neurology and stroke medicine
Zip code
Address
3-9 Fukuura Kanazawa-ku Yokohama
TEL
045-787-2800
Homepage URL
interferon1234@gmail.com
Sponsor or person
Institute
Yokohama City University
Institute
Department
Personal name
Funding Source
Organization
Yokohama City University
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2012 | Year | 05 | Month | 02 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Enrolling by invitation
Date of protocol fixation
| 2012 | Year | 05 | Month | 02 | Day |
Date of IRB
Anticipated trial start date
| 2012 | Year | 05 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2012 | Year | 05 | Month | 01 | Day |
Last modified on
| 2019 | Year | 05 | Month | 26 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009254
